Welcome to LookChem.com Sign In|Join Free
  • or
4-(phenylsulfonyl)-3,4-dihydroquinoxalin-2(1H)-one is a complex organic compound with the molecular formula C15H13NO3S. It is a derivative of quinoxaline, a fused bicyclic ring system consisting of a benzene ring and a pyrazine ring. The compound features a phenylsulfonyl group attached to the 4-position of the quinoxaline core, which contributes to its chemical properties and potential applications. This specific structure may be of interest in medicinal chemistry, as quinoxaline derivatives are known for their diverse biological activities, including potential use as antitumor, antibacterial, and anti-inflammatory agents. The compound's dihydro nature indicates the presence of a double bond that has been reduced to a single bond, which can affect its reactivity and stability. Overall, 4-(phenylsulfonyl)-3,4-dihydroquinoxalin-2(1H)-one is a significant molecule in the field of organic chemistry, with potential implications in pharmaceutical research and development.

4937-77-3

Post Buying Request

4937-77-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

4937-77-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 4937-77-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,9,3 and 7 respectively; the second part has 2 digits, 7 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 4937-77:
(6*4)+(5*9)+(4*3)+(3*7)+(2*7)+(1*7)=123
123 % 10 = 3
So 4937-77-3 is a valid CAS Registry Number.

4937-77-3Relevant academic research and scientific papers

Design, synthesis and biological evaluation of quinoxaline compounds as anti-HIV agents targeting reverse transcriptase enzyme

Estrin, Darío,Fabian, Lucas,Gómez, Natalia,Moglioni, Albertina,Salvatori, Melina,Taverna Porro, Marisa,Turk, Gabriela

, (2020)

Infection by human immunodeficiency virus still represents a continuous serious concern and a global threat to human health. Due to appearance of multi-resistant virus strains and the serious adverse side effects of the antiretroviral therapy administered, there is an urgent need for the development of new treatment agents, more active, less toxic and with increased tolerability to mutations. Quinoxaline derivatives are an emergent class of heterocyclic compounds with a wide spectrum of biological activities and therapeutic applications. These types of compounds have also shown high potency in the inhibition of HIV reverse transcriptase and HIV replication in cell culture. For these reasons we propose, in this work, the design, synthesis and biological evaluation of quinoxaline derivatives targeting HIV reverse transcriptase enzyme. For this, we first carried out a structure-based development of target-specific compound virtual chemical library of quinoxaline derivatives. The rational construction of the virtual chemical library was based on previously assigned pharmacophore features. This library was processed by a virtual screening protocol employing molecular docking and 3D-QSAR. Twenty-five quinoxaline compounds were selected for synthesis in the basis of their docking and 3D-QSAR scores and chemical synthetic simplicity. They were evaluated as inhibitors of the recombinant wild-type reverse transcriptase enzyme. Finally, the anti-HIV activity and cytotoxicity of the synthesized quinoxaline compounds with highest reverse transcriptase inhibitory capabilities was evaluated. This simple screening strategy led to the discovery of two selective and potent quinoxaline reverse transcriptase inhibitors with high selectivity index.

Synthesis and aldose reductase inhibitory activity of N-1,N-4-disubstituted 3,4-dihydro-2(1H)-quinoxalinone derivatives

Sarges,Lyga

, p. 1475 - 1479 (2007/10/02)

Synthetic routes have been developed for the preparation of 4-acylated, 4-benzenesulfonylated, and 4-methylated 3,4-dihydro-2(1H)-quinoxalinone-1-acetic acids. One example of the corresponding propionic acid has also been made. These compounds have been evaluated for their ability to inhibit bovine lens aldose reductase in vitro. Some members from this series also show weak activity in vivo, inhibiting sorbitol formation in sciatic nerves of streptozotocin-diabetic rats.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 4937-77-3